Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232411 · ClinicalTrials.gov registry record
Biobank for African American Prostate Cancer Research in Florida
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 592
- Enrollment target
NCT03232411: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT03232411 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 592 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03232411 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 592 participants
- Enrollment target
Study Summary
The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prostate cancer patients regarding participation. This project has 3 main components. Eligible patients may choose to participate in any or all parts of the study: Questionnaires; Saliva Samples; Tumor Tissue.
Primary Outcome
The study timeline is up to 3 years to collect detailed patients' data, outcome information and bio-specimens from men of African Ancestry with prostate cancer (n=6,000), diagnosed between January 2013 and December 2015.
Interventions
- OTHER Questionnaires
- OTHER Saliva Samples
- OTHER Tumor Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 592 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2024-01-23 |
What the finished NCT03232411 record still lists
NCT03232411 is an observational study that tracks outcomes without assigning an intervention. The registered 592 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT03232411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03232411 about?
NCT03232411 is a clinical study titled "Biobank for African American Prostate Cancer Research in Florida". The purposes of this study are: a) to develop a statewide Biobank for prostate cancer among men of African Ancestry in Florida and; b) to examine whether smoking increases the aggressiveness of prostate cancer using several biological approaches. Investigators plan to contact African American prost...
What is the current status of trial NCT03232411?
This trial is currently completed. The enrollment target is 592 participants. The study started on 2017-03-22. Estimated completion is 2024-01-23.
What interventions are being tested in trial NCT03232411?
The interventions under investigation include: Questionnaires (OTHER), Saliva Samples (OTHER), Tumor Tissue (OTHER).
Who is sponsoring clinical trial NCT03232411?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04701684 · 594 participants · NA
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
- NCT05491213 · 594 participants · NA
TELESCOPE- TELEhealth Shared Decision-making COaching
- NCT05867420 · 594 participants · Phase 1
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
- NCT06890884 · 594 participants · Phase 2
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI